【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯，中恒集团(600252.

智通财经03-19

【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯，中恒集团(600252.SH)发布公告，公司控股子公司重庆莱美药业股份有限公司(简称“莱美药业”)收到国家药品监督管理局核准签发的规格为20mg的奥美拉唑镁肠溶片《药品注册证书》，奥美拉唑镁肠溶片系阿斯利康制药公司开发上市，商品名为洛赛克，剂型为肠溶片，规格：20mg和10mg，临床上用于治疗食管炎、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2420248251?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-19 17:47","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2420248251","market":"uk","top_or_hot":-1,"title":"【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯，中恒集团(600252.","media":"智通财经","content":"<div>\n<p>【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯，中恒集团(600252.SH)发布公告，公司控股子公司重庆莱美药业股份有限公司(简称“莱美药业”)收到国家药品监督管理局核准签发的规格为20mg的奥美拉唑镁肠溶片《药品注册证书》，奥美拉唑镁肠溶片系阿斯利康制药公司开发上市，商品名为洛赛克，剂型为肠溶片，规格：20mg和10mg，临床上用于治疗食管炎、...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=astock\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7x24快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7x24快讯\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-19 17:47 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=astock><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯，中恒集团(600252.SH)发布公告，公司控股子公司重庆莱美药业股份有限公司(简称“莱美药业”)收到国家药品监督管理局核准签发的规格为20mg的奥美拉唑镁肠溶片《药品注册证书》，奥美拉唑镁肠溶片系阿斯利康制药公司开发上市，商品名为洛赛克，剂型为肠溶片，规格：20mg和10mg，临床上用于治疗食管炎、...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=astock\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0889565080.SGD","symbol_name":"FTIF - Templeton European Opportunities A Acc SGD-H1","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","article_id":"2420248251","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2420248251","pubTimestamp":1710841651,"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯，中恒集团(600252.SH)发布公告，公司控股子公司重庆莱美药业股份有限公司(简称“莱美药业”)收到","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300006":"莱美药业","600252":"中恒集团","LU0889565080.SGD":"FTIF - Templeton European Opportunities A Acc SGD-H1","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","BK0077":"质押式回购","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1487256676.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ZUH\" (USDHDG) ACC","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","LU0171293334.USD":"贝莱德英国基金A2","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","BK5011":"制药","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","LU0957799991.USD":"THREADNEEDLE (LUX) PAN EUROPEAN ESG EQUITIES \"ZUH\" (USDHDG) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","03165":"华夏欧优股对冲","BK0015":"沪股通50","LU0963555726.SGD":"Blackrock European Fund A2 SGD-H","LU0526926950.USD":"贝莱德欧洲基金","LU0122379950.USD":"贝莱德世界健康科学A2","AZN.UK":"阿斯利康制药","LU0972486137.USD":"THREADNEEDLE (LUX) PAN EUROPEAN ESG EQUITIES \"AUH\" (USDHDG) ACC","LU0784385840.USD":"Blackrock Global Multi-Asset Income A2 USD","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU0047473722.SGD":"HSBC GIF EUROPE VALUE \"PD\" (SGD) INC","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","SG9999001176.USD":"United Global Healthcare Acc USD","BK0070":"员工持股","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU0757432116.USD":"THREADNEEDLE (LUX) PAN EUROPEAN ESG EQUITIES \"AE\" (USD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","BK0239":"医药制造","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0784384876.USD":"Blackrock Global Multi-Asset Income A6 USD","LU1481599808.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"AUC\" (USDHDG) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0969580561.USD":"贝莱德欧洲特别时机基金A2","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU0047473722.EUR":"HSBC GIF EUROPE VALUE \"PD\" (EUR) INC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1481600234.SGD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ASC\" (SGDHDG) INC"},"translate_title":"[Laimei Pharmaceutical, a subsidiary of Zhongheng Group (600252. SH), received the drug registration certificate for omeprazole magnesium enteric-coated tablets] Zhitong Finance APP News, Zhongheng Group (600252.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300006":1,"600252":1,"AZN.UK":1,"03165":0.6},"content_text":"【中恒集团(600252.SH)子公司莱美药业收到奥美拉唑镁肠溶片药品注册证书】智通财经APP讯，中恒集团(600252.SH)发布公告，公司控股子公司重庆莱美药业股份有限公司(简称“莱美药业”)收到国家药品监督管理局核准签发的规格为20mg的奥美拉唑镁肠溶片《药品注册证书》，奥美拉唑镁肠溶片系阿斯利康制药公司开发上市，商品名为洛赛克，剂型为肠溶片，规格：20mg和10mg，临床上用于治疗食管炎、十二指肠溃疡等疾病。","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420248251"}